An Exploratory Cost-Utility Analysis of Screening and Treating Immigrants in Canada for Hepatitis D. [PDF]
Zhao J +4 more
europepmc +1 more source
The long noncoding RNA MAPKAPK5-AS1 promotes the formation of hepatitis B virus cccDNA by modulating the expression of NABP1. [PDF]
Zhang X +5 more
europepmc +1 more source
Natural History and Clinical Outcomes of HBeAg-Negative Chronic Hepatitis B Patients in the "Grey Zone": A Longitudinal Cohort Study. [PDF]
Xue Y +9 more
europepmc +1 more source
Quantitative HBsAg as a biomarker for disease staging in untreated chronic hepatitis B patients: a cross-sectional study. [PDF]
Mrabet S +7 more
europepmc +1 more source
Virological significance of HBeAg subspecificities (HBeAg/1 and HBeAg/2) in HBsAg carriers
openaire +1 more source
Erratum to 'KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA)' [Clin Mol Hepatol 2026;32:1029-1116]. [PDF]
Choi WM +18 more
europepmc +1 more source
Risk factors for postpartum alanine aminotransferase elevation in women with chronic hepatitis B infection: a systematic review and meta-analysis. [PDF]
Yao C +7 more
europepmc +1 more source
The GOLDEN Model Effectively Predicts Hepatitis B Surface Antigen Seroclearance in Untreated Patients in Real World Clinical Practice. [PDF]
Hao K +6 more
europepmc +1 more source
Factors Associated With Surface Antigen (HBsAg) Clearance in a Spanish Cohort of Chronic Hepatitis B Patients: Influence on the Long-Term Prognosis. [PDF]
Gavilán P +2 more
europepmc +1 more source
Baseline Liver Fibrosis Severity Predicts Superior HBeAg Clearance and Fibrosis Reversal following Peg-IFNα plus Nucleos(t)ide Analog Therapy in HBeAg-positive Chronic Hepatitis B Patients. [PDF]
Zhang Y +8 more
europepmc +1 more source

